Stockscreener 앱 받기
28.84
0.72%
-0.21
전일 마감가:
$29.05
열려 있는:
$29.49
하루 거래량:
2.01M
Relative Volume:
0.74
시가총액:
$3.66B
수익:
$638.78M
순이익/손실:
$-22.66M
주가수익비율:
-165.37
EPS:
-0.1744
순현금흐름:
$122.18M
1주 성능:
-7.09%
1개월 성능:
+37.86%
6개월 성능:
+86.55%
1년 성능:
+172.59%
1일 변동 폭
$28.39
$30.00
1주일 범위
$28.01
$31.68
52주 변동 폭
$10.17
$35.65
10X 제노믹스 Stock (TXG) Company Profile
명칭
10 X Genomics Inc
전화
(925) 401-7300
주소
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, BTSG, TEM, HQY, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
28.84 | 3.66B | 638.78M | -22.66M | 122.18M | -0.1744 |
VEEV
Veeva Systems Inc
|
159.54 | 25.92B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
63.23 | 12.41B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
47.82 | 8.59B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.34 | 7.39B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
65.34 | 5.06B | 646.34M | -512.40M | 202.76M | -6.6871 |
10X 제노믹스 Stock (TXG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-31 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-12-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | 개시 | Piper Sandler | Neutral |
| 2025-02-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-07-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-10 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-05-01 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-10 | 개시 | Barclays | Overweight |
| 2023-03-31 | 개시 | Stephens | Overweight |
| 2023-02-02 | 개시 | UBS | Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-08-18 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-07-25 | 개시 | Canaccord Genuity | Buy |
| 2022-07-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-03-15 | 개시 | William Blair | Outperform |
| 2020-12-02 | 개시 | Goldman | Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-07-10 | 개시 | Stifel | Buy |
| 2020-03-05 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-10-07 | 개시 | BofA/Merrill | Buy |
| 2019-10-07 | 개시 | Cowen | Outperform |
| 2019-10-07 | 개시 | JP Morgan | Overweight |
| 2019-09-24 | 개시 | Evercore ISI | Outperform |
모두보기
10X 제노믹스 주식(TXG)의 최신 뉴스
10x Genomics buys Proteintech Genomics - MSN
TXG Gains From Proteintech Deal, Expands Multiomics Capabilities - TradingView
10x Genomics: Temporary Pain, Long-Term Gain As Atera Rollout Approaches (NASDAQ:TXG) - Seeking Alpha
Is It Too Late To Consider 10x Genomics (TXG) After Its Recent 187% Surge? - Yahoo Finance
10x Genomics (TXG) Expands Capabilities with Proteintech Genomics Acquisition - GuruFocus
10x Genomics Acquires Proteintech Genomics to Expand Single-Cell Proteomics Portfolio - citybiz
Is 10x Genomics' Latest Acquisition a Game-Changer for Proteomics - Kavout
10x Genomics acquires Proteintech Genomics division By Investing.com - Investing.com India
10x Genomics acquires Proteintech Genomics division - Investing.com
10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group - Barchart.com
CenterBook Partners LP Invests $3.76 Million in 10x Genomics $TXG - MarketBeat
10x Genomics (TXG) awards 8,829 RSUs to company director - Stock Titan
10x Genomics (NASDAQ: TXG) grants 8,829 RSUs to director Suliman - Stock Titan
10x Genomics (TXG) awards 8,829 RSUs to board director - Stock Titan
10x Genomics (TXG) awards director Kimberly Popovits 8,829 RSUs - Stock Titan
10x Genomics (TXG) director receives 8,829 RSUs vesting from 2026 - Stock Titan
10x Genomics (TXG) director receives 8,829 RSU grant, lifts holdings - Stock Titan
10x Genomics Shareholders Reelect Directors, Ratify Auditor - TipRanks
10x Genomics, Inc. acquired Proteintech Genomics from ProteinTech Group Inc. - marketscreener.com
10x Genomics shareholders elect directors and approve proposals at annual meeting - Investing.com
10x Genomics (NASDAQ: TXG) investors approve full 2026 meeting agenda - Stock Titan
TXG Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Deutsche Bank Adjusts Price Target on 10x Genomics to $30 From $23, Maintains Hold Rating - marketscreener.com
10x Genomics CEO Sells Nearly 30,000 Shares. Here's What That Means for Investors. - Yahoo Finance
10X Genomics Hits Day High with 9.72% Surge, Outperforming Market - Markets Mojo
10x Genomics stock hits 52-week high at 26.56 USD By Investing.com - Investing.com Nigeria
10x Genomics stock hits 52-week high at 26.56 USD - Investing.com
10x genomics president Hindson sells $283,399 in company stock By Investing.com - Investing.com Australia
10x genomics president Hindson sells $283,399 in company stock - Investing.com UK
10x genomics CEO Serge Saxonov sells $709,057 in shares - Investing.com
10x Genomics CFO Adam Taich sells $369,017 in stock By Investing.com - Investing.com South Africa
10x Genomics CFO Adam Taich sells $369,017 in stock - Investing.com
10x Genomics (NASDAQ: TXG) CEO sells 28,893 shares under 10b5-1 tax-related plan - Stock Titan
10x Genomics (TXG) officer sells 11,595 shares to cover RSU taxes - Stock Titan
10x Genomics (TXG) CFO sells 15,098 shares to cover RSU taxes - Stock Titan
TXG - Finviz
TXG Genomics (NASDAQ: TXG) Serge Saxonov lists recent Class A sales in Form 144 - Stock Titan
Citigroup downgrades 10x Genomics (TXG) - MSN
10x Genomics Inc Class A Trade Ideas — LS:A2PPQJ - TradingView
Serge Saxonov (TXG) reports multiple 2026 sales and a 35,270-share RSU grant - Stock Titan
TXG (NASDAQ) Form 144: RSU grant 26,276 shares; insider sold 7,826 - Stock Titan
Adam Taich to sell 32,648 TXG shares (TXG) - Stock Titan
TXG News | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill
10x Genomics, Inc.Common Stock (NQ: TXG - FinancialContent
10X Genomics’ SWOT analysis: stock faces profitability test - Investing.com
The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call - Yahoo Finance
10x Genomics Q1 earnings call highlights - MSN
The Bull Case For 10x Genomics (TXG) Could Change Following Mixed Q1 Results And Reaffirmed Guidance - Sahm
Precision Trading with 10x Genomics Inc. (TXG) Risk Zones - Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and Solventum Corporation (SOLV) - The Globe and Mail
10X 제노믹스 (TXG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10X 제노믹스 주식 (TXG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Saxonov Serge | Chief Executive Officer |
May 26 '26 |
Sale |
24.71 |
10,718 |
264,833 |
1,138,380 |
| Hindson Benjamin J. | See Remarks |
May 22 '26 |
Sale |
24.44 |
11,595 |
283,399 |
502,000 |
| Taich Adam | Chief Financial Officer |
May 22 '26 |
Sale |
24.44 |
15,098 |
369,018 |
379,898 |
0.10%
0.06%
자본화:
|
볼륨(24시간):